Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma
- Resource Type
- Article
- Authors
- Schlumberger, M. ; Elisei, R.; Müller, S.; Schöffski, P.; Brose, M.; Shah, M.; Licitra, L.; Krajewska, J.; Kreissl, M.C.; Niederle, B.; Cohen, E.E.W.; Wirth, L.; Ali, H.; Clary, D.O.; Yaron, Y.; Mangeshkar, M.; Ball, D.; Nelkin, B.; Sherman, S.
- Source
- In Annals of Oncology November 2017 28(11):2813-2819
- Subject
- Language
- ISSN
- 0923-7534